81 related articles for article (PubMed ID: 28133107)
1. [Characteristics and Outcomes of Treatment in Patients with Stage IV Colorectal Cancer with Mismatch Repair Deficiency].
Ishibashi K; Chika N; Suzuki O; Ito T; Amano K; Kumamoto K; Fukuchi M; Kumagai Y; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1711-1714. PubMed ID: 28133107
[TBL] [Abstract][Full Text] [Related]
2. Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain.
Garcia-Carbonero R; González Astorga B; Vidal Tocino R; Contreras Toledo D; Pericay C; Fernández Montes A; Falcó E; González Cordero M; Reina Zoilo JJ; Alonso V; Rodríguez Salas N; Gil-Raga M; Santos C; Páez D; Anton-Pascual B; Aguilar F; Morales P
Clin Transl Oncol; 2024 Apr; 26(4):864-871. PubMed ID: 37651021
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of Deficient Mismatch Repair in Stage II-IVa Nasopharyngeal Carcinoma in the Era of IMRT.
Chen FM; Zhang YX; Li XF; Gao JF; Ma H; Wang XL; Li Y; Li C; Zhang YN; Zhang YT; Kan HX; Li H; Zhang SG; Hao FR; Wang MC
Sci Rep; 2020 Jun; 10(1):9690. PubMed ID: 32546739
[TBL] [Abstract][Full Text] [Related]
4. Synchronous and metachronous primary colorectal cancers with concordant and discordant mismatch repair status.
Carlin L; Paudice M; Ingaliso M; Pigozzi S; Trevisan L; Sciallero S; Pastorino A; Piol N; Grillo F; Mastracci L
Hum Pathol; 2023 Nov; 141():54-63. PubMed ID: 37742947
[TBL] [Abstract][Full Text] [Related]
5. Mismatch Repair Deficiency Is a Prognostic Factor Predicting Good Survival of
Khuntikeo N; Padthaisong S; Loilome W; Klanrit P; Ratchatapusit S; Techasen A; Jareanrat A; Thanasukarn V; Srisuk T; Luvira V; Chindaprasirt J; Sa-Ngiamwibool P; Aphivatanasiri C; Intarawichian P; Koonmee S; Prajumwongs P; Titapun A
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835526
[TBL] [Abstract][Full Text] [Related]
6. SOMATIC DEFICIENT MISMATCH REPAIR ASSESSED BY IMMUNOHISTOCHEMISTRY AND CLINICAL FEATURES IN BRAZILIAN GLIOBLASTOMA PATIENTS.
Yamada CAF; Malheiros SMF; Do Amaral LLF; Lancellotti CLP
Exp Oncol; 2023 Dec; 45(3):297-311. PubMed ID: 38186025
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and molecular analysis of microsatellite instability in prostate cancer: a multi-institutional study in China.
Zhang H; Yang X; Xie J; Cheng X; Chen J; Shen M; Ding W; Wang S; Zhang Z; Wang C; Zhao M
Front Oncol; 2023; 13():1277233. PubMed ID: 37901334
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair protein deficiency and its implications on distant metastasis in colorectal cancer: A comprehensive analysis.
Fan C; Fang C; Wang W; Lv Z; Zhang X; Long F; Jiang Z; Li Y; Zhang H; Zhou ZG; Wang C; Sun XF
Cancer Med; 2024 Apr; 13(7):e6994. PubMed ID: 38545852
[TBL] [Abstract][Full Text] [Related]
9. Preoperative contrast-enhanced CT imaging and clinicopathological characteristics analysis of mismatch repair-deficient colorectal cancer.
Chen S; Du W; Cao Y; Kong J; Wang X; Wang Y; Lu Y; Li X
Cancer Imaging; 2023 Oct; 23(1):97. PubMed ID: 37828626
[TBL] [Abstract][Full Text] [Related]
10. The impact of mismatch repair status and systemic inflammatory markers on radiological staging in colon cancer.
Platt JR; Ansett J; Seligmann JF; West NP; Tolan DJM
Br J Radiol; 2023 Oct; 96(1150):20230098. PubMed ID: 37493144
[TBL] [Abstract][Full Text] [Related]
11. Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).
Okuma HS; Watanabe K; Tsuchihashi K; Machida R; Sadachi R; Hirakawa A; Ariyama H; Kanai M; Kamikura M; Anjo K; Hiramitsu A; Sekine S; Okita N; Mano H; Nishikawa H; Nakamura K; Yonemori K
Clin Cancer Res; 2023 Dec; 29(24):5079-5086. PubMed ID: 37819940
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Mismatch Repair Status on Prognosis of Patients With Gastric Cancer: A Multicenter Analysis.
Guan WL; Ma Y; Cui YH; Liu TS; Zhang YQ; Zhou ZW; Xu JY; Yang LQ; Li JY; Sun YT; Xu RH; Wang FH; Qiu MZ
Front Oncol; 2021; 11():712760. PubMed ID: 34900669
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer.
Oh CR; Kim EJ; Chae H; Park YS; Ryu MH; Kim HD; Kang YK
Gastric Cancer; 2024 Mar; ():. PubMed ID: 38555561
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of mismatch repair deficiency in Chinese colorectal cancers: a multicenter study.
Jiang W; Sui QQ; Li WL; Ke CF; Ling YH; Liao LE; Zhu Z; Cai MY; Luo J; Mao LL; Zhang HZ; Wan DS; Pan ZZ; Ju HX; Ding PR
Gastroenterol Rep (Oxf); 2020 Oct; 8(5):399-403. PubMed ID: 33163196
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Patients With Early-Stage Mismatch Repair Deficient Colorectal Cancer Receiving Neoadjuvant Immunotherapy: A Systematic Review.
Chakrabarti S; Grewal US; Vora KB; Parikh AR; Almader-Douglas D; Mahipal A; Sonbol MBB
JCO Precis Oncol; 2023 Aug; 7():e2300182. PubMed ID: 37595183
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone.
Ni K; Zhan Y; Liu Z; Yuan Z; Wang S; Zhao XZ; Ping H; Liu Y; Wang W; Yan S; Xin R; Han Q; Zhang Q; Li G; Zhang X; Wang G; Zhang Z; Ma H; Zhang C
BMC Cancer; 2023 Oct; 23(1):1013. PubMed ID: 37864137
[TBL] [Abstract][Full Text] [Related]
17. Deficient Mismatch Repair Proteins in Gastric Mixed Neuroendocrine Non-Neuroendocrine Neoplasm: A Rare Case Report.
Nguyen THC; Nguyen Tran BS; Nguyen TP; Ha TMT; Pham NC; Nguyen TGT; Hoang H; Dang Cong T
Case Rep Oncol; 2023; 16(1):1172-1182. PubMed ID: 37900850
[TBL] [Abstract][Full Text] [Related]
18. HER2 Overexpression and Mismatch Repair Deficiency are Correlated with Malignancy in Colorectal Cancer.
Luo H; Cui L; Shen K; Li R; Wang Z; Xie Z
Cancer Manag Res; 2021; 13():3443-3454. PubMed ID: 33907467
[TBL] [Abstract][Full Text] [Related]
19. DNA mismatch repair system regulates the expression of PD-L1 through DNMTs in cervical cancer.
Guo F; Lu R; Kong W; Anwar M; Feng Y
Cancer Cell Int; 2024 Jan; 24(1):25. PubMed ID: 38200495
[TBL] [Abstract][Full Text] [Related]
20. Current status and prospect of immunotherapy for colorectal cancer.
Yang W; Zheng H; Lv W; Zhu Y
Int J Colorectal Dis; 2023 Nov; 38(1):266. PubMed ID: 37962772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
